My Research – Session 5: Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation

Session 5 (Wednesday 15th September at 19:00 BST) in Collaboration with COSACPG

 

 

Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/

 

We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The session will be delivered by: Julian Lindsay

Julian Lindsay (BPharm, MClinPharm, PhD candidate) is a Bone Marrow Transplant (BMT) Pharmacist at Royal North Shore Hospital in Sydney, Australia and a research fellow and PhD candidate at the National Center for Infection in Cancer (NCIC) at the Peter MacCallum Cancer Centre in Melbourne, Australia. His research interest is prevention of infections in patients with blood cancers and those undergoing bone marrow transplants including cytomegalovirus, Epstein-barr virus and invasive fungal infections. He will be conducting research full time in Seattle, USA, at The Fred Hutchinson Cancer Research Centre, in conjunction with the Peter MacCallum Cancer Centre in Melbourne, Australia. The research aims to address the critical knowledge gaps related to the optimization of antifungal prophylaxis, involving large scale clinical studies of patient outcomes when using new antifungal medications, as well as optimisation of antifungal dosing using pharmacogenomic testing to improve outcomes.

 

 

 

 

 

 

 

 

The session will be chaired by: Nick Duncan

Nick is an Academic Practitioner in the School of Pharmacy at the University of Birmingham and Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust, UK. He qualified as a pharmacist in 1994 and has spent most of his career to date working in oncology and haematology, particularly in the area of haematopoietic stem cell transplantation. He qualified as an independent prescriber in 2010 and has an active prescribing role in a variety of haematology clinics. Areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

 

Nick is Secretary of the UK BMT Pharmacists Group – https://www.bopa.org.uk/membergroups/affiliated-groups/bmt-group/

 

 

 

 

 

Please Note:

-Webinars will start at 19:00 BST and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day of the event around 17:30pm (if you would like the link before this time please email [email protected])

-Webinars are FREE to access for BOPA Paid and BOPA FREE Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this LINK

 

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article